2018年4期
Cancer Drug Resistance
- Acknowledgement to reviewers of Cancer Drug Resistance in 2018
- What really matters - response and resistance in cancer therapy
- Antibody drug conjugate development in gastrointestinal cancers: hopes and hurdles from clinical trials
- Epigenetics, a key player of immunotherapy resistance
- Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer
- Wilms' tumor gene (WT1) is strongly expressed in high-risk subsets of pediatric acute lymphoblastic leukemia
- Meeting Abstracts of the BACR conference:response and resistance in cancer therapy